PEDIATRICS Vol. 48 No. 4 October 1971, pp. 605-612
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bau, S. K.
Right arrow Articles by Levison, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bau, S. K.
Right arrow Articles by Levison, H.

THE MEASUREMENT OF FLUID DEPOSITION IN HUMANS FOLLOWING MIST TENT THERAPY

Samuel K. Bau M.D.1, Norman Aspin Ph.D.1, Donald E. Wood M.D., F.R.C.P.(C)1, and Henry Levison M.D.1

1 Departments of Paediatrics, Medicine and Medical Biophysics, Faculty of Medicine, University of Toronto; The Research Institute, and the Division of Nuclear Medicine; The Hospital for Sick Children, Toronto, Ontario, Canada

Mist tent therapy is used in the treatment of cystic fibrosis to deposit fluid droplets in the terminal airways of the lung. It is assumed that water deposited in the peripheral airways thins the secretions and facilitates their clearance from the lung.

The distribution of inhaled mist was assessed by labelling aerosol from an ultrasonic nebulizer with technetium 99m and measuring the distribution of radioactivity in a subject who breathed the aerosol in the mist tent. Subjects breathed from the tent for 1 hour after which the total uptake of fluid was measured by a scintillation probe and its distribution with a rectilinear scanner. Three different ultrasonic nebulizers were used. In some studies 10% propylene glycol in water was used as the nebulizing fluid.

In six healthy adults and eight patients with cystic fibrosis, less than 5% of the activity nebulized and distributed in the tent entered the body. Of this, 90% of the inhaled radioactivity initially lodged in the nasopharynx and rapidly appeared in the stomach. Very little activity was detected over the lungs. These results indicate that very little aerosol fluid from a mist tent is directly deposited in the terminal airways of the lung.

Submitted on February 8, 1971
Accepted on April 8, 1971